|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | L-theanine relieves positive, activation, and anxiety symptoms in patients with schizophrenia and schizoaffective disorder: an 8-week, randomized, double-blind, placebo-controlled, 2-center study显示文摘 | Ritsner MS Miodownik C Ratner Y | 2011 | J Clin Psychiatry2011，72，1： | 1 |
| 2 | L-theanine relieves positive,activation,and anxiety symptoms in patients with schizophrenia and schizoaffective disorder:an 8-week,randomized,double-blind,placebo-controlled,2-center stud显示文摘 | Ritsner MS Miodownik C Ratner Y | 2011 | Journal of Clinical Psychiatry2011，72，1： | 1 |
| 3 | Factor structure in the Camberwell Assessment of Need - Patient Version: the correlations with dimensions ofillness, personality and quality of life of schizophrenia patients显示文摘 | Ritsner MS Lisker A Arbitman M | 2012 | Psychiatry Clin Neurosci2012，66，6： | 1 |
| 4 | Predicting quality of life impairment in chronic schizophrenia from cognitive variables显示文摘 | Ritsner MS | 2007 | Qual Life Res2007，16，6： | 1 |
| 5 | Pregnenolone and dehy- droepiandrosterone as an adjunctive treatment in schizophrenia and schizoaffective disorder: an 8-week, double-blind, random- ized, controlled, 2-center, parallel-group trial显示文摘 | Ritsner MS Gibel A Shleifer T | 2010 | J Clin Psy- chiatry2010，71，10： | 1 |
| 6 | Familiality in a five factor model of schizophrenia psychopathology:findings from a 16-month follow-up study显示文摘 | Ritsner MS Ratuer Y Gibel A | 2005 | Psychiatry Res2005，136，23： | 1 |
| 7 | Neurocognitive effects of ziprasidone and related factors in patients with chronic schizophreniaundergoing usual care:a 12-month,open-label,flexible-dose,naturalistic observational trial显示文摘 | Gibel A Ritsner MS | | 0，，： | 1 |
| 8 | L-theanine relieves positive,activation,and anxiety symptoms in patients with schizophrenia and schizoaffective disorder:an 8-week,randomized,double-blind,placebo-controlled,2-center study显示文摘 | Ritsner MS Miodownik C Ratner Y | 2011 | J Clin Psychiatry2011，72，1： | 1 |
| 9 | Neurocognitive effects of ziprasidone and related factors in patients with chronic schizophrenia undergoing usual care: a 12-month, open-labe|, flexible-dose, naturalistic observational trial显示文摘 | GIBEL A RITSNER MS | 2008 | Clinical Neuropharmacology2008，31，4： | 1 |
| 10 | Adjunctive pregnenolone amel- iorates the cognitive deficits in recent-onset schizophrenia显示文摘 | Kreinin A Bawakny N Ritsner MS | 2014 | Clin Schizophr Relat Psychoses2014，4，： | 1 |
| 11 | Anhedonia of patients with schizophrenia and schizoaffective disorder is attributed to personality-related factors rather than to state-dependent clinical symptoms显示文摘 | Ritsner MS | 2013 | Clin Schizophr Relat Psychoses2013，21，： | 1 |
| 12 | Anhedonia is an important factor of health-related quality-of-fife deficit in schizophrenia and schizoaffec- tive disorder 显示文摘 | Ritsner MS Arbitman M Lisker A | 2011 | J Nerv Ment Dis2011，199，11： | 1 |
| 13 | Predicting quality of life impairment in chronic schizophrenia from cognitive variables显示文摘 | Ritsner MS | 2007 | Qual Life Res2007，16，7： | 1 |
| 14 | Predicting quality of life impairment in chronic schizophrenia from cognitive variables 显示文摘 | Ritsner MS | 2007 | Qual Life Res2007，16，6： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员